S&P 500   3,768.47
DOW   30,924.14
QQQ   304.10
S&P 500   3,768.47
DOW   30,924.14
QQQ   304.10
S&P 500   3,768.47
DOW   30,924.14
QQQ   304.10
S&P 500   3,768.47
DOW   30,924.14
QQQ   304.10
Log in
NASDAQ:LIFE

aTyr Pharma News Headlines

$4.44
+0.12 (+2.78 %)
(As of 03/4/2021 12:00 AM ET)
Add
Compare
Today's Range
$4.21
Now: $4.44
$4.48
50-Day Range
$3.53
MA: $4.79
$8.06
52-Week Range
$2.13
Now: $4.44
$8.33
Volume523,937 shs
Average Volume1.17 million shs
Market Capitalization$45.22 million
P/E RatioN/A
Dividend YieldN/A
Beta2.17

Headlines

aTyr Pharma (NASDAQ LIFE) News Headlines Today

Source:
SourceHeadline
aTyr Pharma, Inc. (NASDAQ:LIFE) Short Interest UpdateaTyr Pharma, Inc. (NASDAQ:LIFE) Short Interest Update
americanbankingnews.com - March 2 at 4:00 AM
aTyr Pharma (NASDAQ:LIFE) Trading Up 7.4%aTyr Pharma (NASDAQ:LIFE) Trading Up 7.4%
americanbankingnews.com - March 1 at 7:59 PM
aTyr Pharma, Inc. (NASDAQ:LIFE) Expected to Announce Earnings of -$0.80 Per ShareaTyr Pharma, Inc. (NASDAQ:LIFE) Expected to Announce Earnings of -$0.80 Per Share
americanbankingnews.com - February 25 at 8:38 AM
aTyr Pharma to Present at March Investor ConferencesaTyr Pharma to Present at March Investor Conferences
finance.yahoo.com - February 25 at 8:18 AM
aTyr Pharma (NASDAQ:LIFE) Stock Price Down 9.9%aTyr Pharma (NASDAQ:LIFE) Stock Price Down 9.9%
americanbankingnews.com - February 23 at 8:12 PM
7 Stocks With Important Insider Trading Signals That Say Sell7 Stocks With Important Insider Trading Signals That Say Sell
finance.yahoo.com - February 20 at 7:57 AM
aTyr Pharma (NASDAQ:LIFE)  Shares Down 7.1% aTyr Pharma (NASDAQ:LIFE) Shares Down 7.1%
americanbankingnews.com - February 17 at 8:17 PM
aTyr Pharma, Inc. (NASDAQ:LIFE) Short Interest Down 30.6% in JanuaryaTyr Pharma, Inc. (NASDAQ:LIFE) Short Interest Down 30.6% in January
americanbankingnews.com - February 15 at 2:46 PM
aTyr Pharma Announces New tRNA Synthetase Discovery ProgramsaTyr Pharma Announces New tRNA Synthetase Discovery Programs
finance.yahoo.com - February 11 at 8:56 AM
aTyr Pharma (NASDAQ:LIFE) Trading Down 8.3%aTyr Pharma (NASDAQ:LIFE) Trading Down 8.3%
americanbankingnews.com - February 9 at 9:06 PM
The aTyr Pharma (NASDAQ:LIFE) Share Price Is Up 103% And Shareholders Are Boasting About ItThe aTyr Pharma (NASDAQ:LIFE) Share Price Is Up 103% And Shareholders Are Boasting About It
finance.yahoo.com - February 9 at 9:24 AM
aTyr Pharma to Present at BIO CEO & Investor Digital ConferenceaTyr Pharma to Present at BIO CEO & Investor Digital Conference
finance.yahoo.com - February 9 at 9:24 AM
2 “Strong Buy” Penny Stocks With Over 200% Upside on the Horizon2 “Strong Buy” Penny Stocks With Over 200% Upside on the Horizon
finance.yahoo.com - February 4 at 12:51 PM
aTyr Pharma Presents Findings Further Validating NRP2 as a Potential Regulator of Solid Tumor ProgressionaTyr Pharma Presents Findings Further Validating NRP2 as a Potential Regulator of Solid Tumor Progression
finance.yahoo.com - January 25 at 8:21 AM
aTyr Pharma to Present Poster Highlighting Research Approach for Identifying Receptor Targets for Extracellular tRNA SynthetasesaTyr Pharma to Present Poster Highlighting Research Approach for Identifying Receptor Targets for Extracellular tRNA Synthetases
finance.yahoo.com - January 22 at 10:52 AM
aTyr Pharma Announces Partner Kyorin Pharmaceutical, Co., Ltd. Completes Subject Visits for Phase 1 Trial of ATYR1923 in JapanaTyr Pharma Announces Partner Kyorin Pharmaceutical, Co., Ltd. Completes Subject Visits for Phase 1 Trial of ATYR1923 in Japan
finance.yahoo.com - January 14 at 5:46 PM
aTyr Pharma to Present at H.C. Wainwright Virtual BioConnect ConferenceaTyr Pharma to Present at H.C. Wainwright Virtual BioConnect Conference
finance.yahoo.com - January 7 at 10:31 AM
aTyr Pharma Announces Positive Topline Results from Phase 2 Clinical Trial of ATYR1923 in COVID-19 Patients with Severe Respiratory ComplicationsaTyr Pharma Announces Positive Topline Results from Phase 2 Clinical Trial of ATYR1923 in COVID-19 Patients with Severe Respiratory Complications
finance.yahoo.com - January 4 at 6:34 PM
aTyr Pharma Announces Completion of Enrollment in Phase 1b/2a Clinical Trial of ATYR1923 in Patients with Pulmonary SarcoidosisaTyr Pharma Announces Completion of Enrollment in Phase 1b/2a Clinical Trial of ATYR1923 in Patients with Pulmonary Sarcoidosis
finance.yahoo.com - December 21 at 8:38 AM
50 Stocks Moving in Fridays Pre-Market Session50 Stocks Moving in Friday's Pre-Market Session
msn.com - December 11 at 7:46 AM
Is aTyr Pharma (LIFE) A Good Stock To Buy Now?Is aTyr Pharma (LIFE) A Good Stock To Buy Now?
finance.yahoo.com - December 3 at 1:26 AM
aTyr Pharma, Inc. (LIFE) CEO Sanjay Shukla on Q3 2020 Results - Earnings Call TranscriptaTyr Pharma, Inc. (LIFE) CEO Sanjay Shukla on Q3 2020 Results - Earnings Call Transcript
seekingalpha.com - November 13 at 7:27 AM
aTyr Pharma EPS beats by $0.06, beats on revenueaTyr Pharma EPS beats by $0.06, beats on revenue
seekingalpha.com - November 12 at 6:12 PM
aTyr Pharma Announces Third Quarter 2020 Results and Provides Corporate UpdateaTyr Pharma Announces Third Quarter 2020 Results and Provides Corporate Update
finance.yahoo.com - November 12 at 6:12 PM
aTyr Pharma Announces Publication in the Journal mAbsaTyr Pharma Announces Publication in the Journal mAbs
finance.yahoo.com - November 11 at 7:08 AM
aTyr Pharma Announces Discovery of New Receptor Targets for Two tRNA Synthetases from its PipelineaTyr Pharma Announces Discovery of New Receptor Targets for Two tRNA Synthetases from its Pipeline
finance.yahoo.com - November 10 at 7:48 AM
Atyr Pharma (LIFE) May Report Negative Earnings: Know the Trend Ahead of Q3 ReleaseAtyr Pharma (LIFE) May Report Negative Earnings: Know the Trend Ahead of Q3 Release
finance.yahoo.com - November 5 at 2:46 PM
aTyr Pharma to Webcast Conference Call Reporting Third Quarter 2020 Financial Results - Management to host conference call and webcast on November 12th at 5:00 pm EST / 2:00 pm PSTaTyr Pharma to Webcast Conference Call Reporting Third Quarter 2020 Financial Results - Management to host conference call and webcast on November 12th at 5:00 pm EST / 2:00 pm PST
finance.yahoo.com - November 5 at 9:46 AM
aTyr Pharma Announces Research Collaboration with Medical University of South CarolinaaTyr Pharma Announces Research Collaboration with Medical University of South Carolina
finance.yahoo.com - October 29 at 8:55 AM
aTyr Pharma to Participate in ROTH Capital Partners Webinar on COVID-19 Therapeutics in Development on October 28thaTyr Pharma to Participate in ROTH Capital Partners Webinar on COVID-19 Therapeutics in Development on October 28th
finance.yahoo.com - October 27 at 7:57 AM
aTyr Pharma concludes enrollment in mid-stage ATYR1923 study in COVID-19 patientsaTyr Pharma concludes enrollment in mid-stage ATYR1923 study in COVID-19 patients
seekingalpha.com - October 26 at 9:16 AM
aTyr Pharma Announces Completion of Enrollment in Phase 2 Clinical Trial of ATYR1923 in COVID-19 Patients with Severe Respiratory ComplicationsaTyr Pharma Announces Completion of Enrollment in Phase 2 Clinical Trial of ATYR1923 in COVID-19 Patients with Severe Respiratory Complications
finance.yahoo.com - October 26 at 9:16 AM
aTyr Falters on Stock OfferingaTyr Falters on Stock Offering
baystreet.ca - September 21 at 2:52 PM
Dosing in Phase 1 trial in aTyr Pharmas ATYR1923 conducted in JapanDosing in Phase 1 trial in aTyr Pharma's ATYR1923 conducted in Japan
seekingalpha.com - September 15 at 9:28 AM
aTyr Pharma Announces Partner Kyorin Pharmaceutical, Co., Ltd. Doses First Subjects in Phase 1 Trial of ATYR1923 in JapanaTyr Pharma Announces Partner Kyorin Pharmaceutical, Co., Ltd. Doses First Subjects in Phase 1 Trial of ATYR1923 in Japan
finance.yahoo.com - September 15 at 9:28 AM
aTyr pharma announces $20M common stock purchase agreementaTyr pharma announces $20M common stock purchase agreement
seekingalpha.com - September 14 at 1:26 PM
aTyr Pharma to Present at September Investor ConferencesaTyr Pharma to Present at September Investor Conferences
finance.yahoo.com - September 9 at 9:33 AM
aTyr Pharma to Present at Life Sciences Investor Forum on September 17thaTyr Pharma to Present at Life Sciences Investor Forum on September 17th
finance.yahoo.com - September 2 at 8:35 AM
Oppenheimer: These 3 Penny Stocks Have Triple-Digit Upside PotentialOppenheimer: These 3 Penny Stocks Have Triple-Digit Upside Potential
finance.yahoo.com - September 1 at 5:33 PM
aTyr Pharma, Inc. (LIFE) CEO Sanjay Shukla on Q2 2020 Results - Earnings Call TranscriptaTyr Pharma, Inc. (LIFE) CEO Sanjay Shukla on Q2 2020 Results - Earnings Call Transcript
seekingalpha.com - August 14 at 2:59 AM
Atyr Pharma (LIFE) Reports Q2 Loss, Misses Revenue EstimatesAtyr Pharma (LIFE) Reports Q2 Loss, Misses Revenue Estimates
finance.yahoo.com - August 13 at 9:59 PM
aTyr Pharma EPS beats by $0.04, misses on revenueaTyr Pharma EPS beats by $0.04, misses on revenue
seekingalpha.com - August 13 at 4:59 PM
aTyr Pharma Announces Second Quarter 2020 Results and Provides Corporate Update on ATYR1923 Clinical Trial ProgramsaTyr Pharma Announces Second Quarter 2020 Results and Provides Corporate Update on ATYR1923 Clinical Trial Programs
finance.yahoo.com - August 13 at 4:59 PM
Japans PMDA signs off on early-stage study of ATYR1923Japan's PMDA signs off on early-stage study of ATYR1923
seekingalpha.com - August 11 at 5:43 PM
aTyr Pharma Announces Partner Kyorin Pharmaceutical, Co., Ltd. Proceeds to Phase 1 Trial of ATYR1923 in JapanaTyr Pharma Announces Partner Kyorin Pharmaceutical, Co., Ltd. Proceeds to Phase 1 Trial of ATYR1923 in Japan
finance.yahoo.com - August 11 at 5:43 PM
aTyr Pharma to Webcast Conference Call Reporting Second Quarter 2020 Financial ResultsaTyr Pharma to Webcast Conference Call Reporting Second Quarter 2020 Financial Results
finance.yahoo.com - August 6 at 10:44 AM
Atyr Pharma (LIFE) May Report Negative Earnings: Know the Trend Ahead of Q2 ReleaseAtyr Pharma (LIFE) May Report Negative Earnings: Know the Trend Ahead of Q2 Release
finance.yahoo.com - August 5 at 6:21 PM
aTyr Pharma IncaTyr Pharma Inc
www.bloomberg.com - July 26 at 7:32 PM
Edited Transcript of LIFE earnings conference call or presentation 12-May-20 9:00pm GMTEdited Transcript of LIFE earnings conference call or presentation 12-May-20 9:00pm GMT
finance.yahoo.com - June 22 at 7:15 PM
aTyr Pharma Presents Preclinical Research Showing NRP2 Antibody Effects in Triple-Negative Breast Cancer at the 2020 AACR Virtual Annual Meeting IIaTyr Pharma Presents Preclinical Research Showing NRP2 Antibody Effects in Triple-Negative Breast Cancer at the 2020 AACR Virtual Annual Meeting II
finance.yahoo.com - June 22 at 9:12 AM
This page was last updated on 3/5/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.